Key result
Commercial wearable devices demonstrated good compliance in elderly patients undergoing SAVR (75.1%) and TAVR (79.8%).
Why the study?
Wearable devices can objectively assess patient-reported outcomes in clinical trials, but the feasibility and acceptability of commercial wearable devices in elderly patients undergoing TAVR or SAVR needed exploration.
Is the use of commercial wearable devices feasible and acceptable for monitoring outcomes in elderly patients undergoing TAVR or SAVR?
Observational
Is the use of commercial wearable devices feasible and acceptable for monitoring outcomes in elderly patients undergoing TAVR or SAVR?
Absolute Event Rate: 75.1% vs 79.8%
Commercial wearable devices are feasible and acceptable for monitoring patient-reported outcomes in frail elderly patients undergoing aortic valve replacement.
Supports wearable monitoring feasibility in elderly SAVR/TAVR patients; leaves open clinical outcome benefits pending prospective trials.
Wearable devices (WDs) can objectively assess patient-reported outcomes (PROMs) in clinical trials. In this study, the feasibility and acceptability of using commercial WDs in elderly patients undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) will be explored. This is a prospective observational study. Participants were trained to use a WD and a smartphone to collect data on their physical activity, rest heart rate and number of hours of sleep. Validated questionnaires were also used to evaluate these outcomes. A technology acceptance questionnaire was used at the end of the follow up. In our participants an overall good compliance in wearing the device (75.1% vs. 79.8%, SAVR vs. TAVR) was assessed. Half of the patients were willing to continue using the device. Perceived ease of use is one of the domains that scored higher in the technology acceptance questionnaire. In this study we observed that the use of a WD is accepted in our frail population for an extended period. Even though commercial WDs are not tailored for clinical research, they can produce useful information on patient behavior, especially when coordinated with intervention tailored to the single patient.
No takes yet. Share an insight, caveat, or question.
Ocagli et al. (2021) conducted an observational in Transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR). Commercial wearable devices vs. SAVR vs TAVR was evaluated on Compliance in wearing the device. Commercial wearable devices demonstrated good compliance in elderly patients undergoing SAVR (75.1%) and TAVR (79.8%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: